Real-Life Data on Hydroxychloroquine or Chloroquine with or Without Azithromycin in COVID-19 Patients: A Retrospective Analysis in Brazil.
Maíra Viana Rego Souza E SilvaDaniella Nunes PereiraMagda Carvalho PiresIsabela Muzzi VasconcelosAlexandre Vargas SchwarzboldDiego Henrique de VasconcelosElayne Crestani PereiraEuler Roberto Fernandes ManentiFelício Roberto CostaFilipe Carrilho de AguiarFernando AnschauFrederico BartolazziGuilherme Fagundes NascimentoHeloisa Reniers ViannaJoanna d'Arc Lyra BatistaJuliana Rodrigues Machado RúgoloKaren Brasil RuschelMaria Angélica Pires FerreiraLeonardo Seixas de OliveiraLuanna da Silva Monteiro MenezesPatricia Klarmann ZiegelmannMarcela Gonçalves Trindade TofaniMaria Aparecida Camargos BicalhoMatheus Carvalho Alves NogueiraMilton Henriques Guimarães-JúniorRúbia Laura Oliveira AguiarDanyelle Romana Alves RiosCarísi Anne PolanczykMilena Soriano MarcolinoPublished in: Arquivos brasileiros de cardiologia (2023)
COVID-19 patients treated with chloroquine or hydroxychloroquine had a longer hospital length of stay, when compared to matched controls. Intensive care unit admission, invasive mechanical ventilation, dialysis and in-hospital mortality were similar.
Keyphrases
- mechanical ventilation
- intensive care unit
- sars cov
- coronavirus disease
- acute respiratory distress syndrome
- plasmodium falciparum
- chronic kidney disease
- respiratory failure
- emergency department
- electronic health record
- end stage renal disease
- healthcare
- big data
- adverse drug
- peritoneal dialysis
- data analysis
- drug induced